Loading clinical trials...
Loading clinical trials...
A Double-Blind, Placebo-Controlled, Randomized, Single and Multiple Dose Study on the Safety, Pharmacokinetics, and Exploratory Pharmacodynamics of Subcutaneous and Intravenous BMS-986325 Administration in Healthy Participants and Participants With Primary Sjögren's Syndrome
Conditions
Interventions
BMS-986325
Placebo for BMS-986325
Locations
2
United States
Medvin Clinical Research - Metyas
Covina, California, United States
Local Institution - 0001
Berlin, Germany
Start Date
February 16, 2021
Primary Completion Date
July 25, 2023
Completion Date
July 25, 2023
Last Updated
August 23, 2023
NCT06342713
NCT07310901
NCT07471204
NCT07401472
NCT07412353
NCT07280858
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions